Clinical Trial Update: Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing short-term versus long-term valganciclovir therapy in infants with symptomatic congenital cytomegalovirus infection; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Drugs mentioned

• Valcyte (valganciclovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Infection | Phase 3 | Status: COMPLETED | Results posted: 2013-11-13